Abstract
The ruthenium(III) complex Hlnd trans-[RuCl4(ind)2], with two trans-standing indazole (ind) ligands bound to ruthenium via nitrogen, shows remarkable activity in different tumor models in vitro and in vivo. The solvolysis of the complex trans-[RuCl4(ind)2] has been investigated by means of spectroscopic techniques (UV/vis, NMR) in different solvents. We investigated the indazolium as well as the sodium salt, the latter showing improved solubility in water. In aqueous acetonitrile and ethanol the solvolysis results in one main solvento complex. The hydrolysis of the complex is more complicated and depends on the pH of the solution as well as on the buffer system.
| Original language | English |
|---|---|
| Pages (from-to) | 225-232 |
| Number of pages | 8 |
| Journal | Metal-Based Drugs : MBD |
| Volume | 7 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2000 |
Austrian Fields of Science 2012
- 1040 Chemistry
Fingerprint
Dive into the research topics of 'Solvolysis of the tumor-inhibiting ru(III)-complex trans-tetrachlorobis(indazole)ruthenate(III)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver